Botulinum Toxin Type A as a Migraine Preventive Treatment

2000541 citationsJournal Articlebronze Open Access

Authors

Stephen D. Silberstein · Thomas Jefferson University

Ninan T. Mathew · Diamond Headache Clinic

Joel R. Saper · Michigan Headache and Neurological Institute

Abstract

Pericranial injection of botulinum toxin type A, 25 U, was found to be a safe treatment that significantly reduced migraine frequency, migraine severity, acute medication usage, and associated vomiting.

Topics & Keywords

Botulinum Toxin and Related Neurological Disorders Sympathectomy and Hyperhidrosis Treatments Ophthalmology and Eye Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Headache The Journal of Head and Face Pain

Volume 40, Issue 6, pp. 445-450

DOI: 10.1046/j.1526-4610.2000.00066.x

Field-Weighted Citation Impact: 27.02